Targeting immune checkpoints on myeloid cells: current status and future directions
Cancer Immunology, Immunotherapy · 2025
DOI: 10.1007/s00262-024-03856-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Chuhan Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shengjing Hospital of China Medical University, ShenyangLiaoning Province, 110004, China. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Immune Checkpoint Proteins, Myeloid Cells, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shengjing Hospital.
Abstract (Originalsprache)
Myeloid cells accumulate extensively in most tumors and play a critical role in immunosuppression of the tumor microenvironment (TME). Like T cells, myeloid cells also express immune checkpoint molecules, which induce the immunosuppressive phenotype of these cells. In this review, we summarize the tumor-promoting function and immune checkpoint expression of four types of myeloid cells: macrophages, neutrophils, dendritic cells, and myeloid-derived suppressor cells, which are the main components of the TME. By summarizing the research status of myeloid checkpoints, we propose that blocking immune checkpoints on myeloid cells might be an effective strategy to reverse the immunosuppressive status of the TME. Moreover, combining nanotechnology, cellular therapy, and bispecific antibodies to achieve precise targeting of myeloid immune checkpoints can help to avoid the adverse effects of systemic administration, ultimately achieving a balance between efficacy and safety in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Shengjing Hospital of China Medical University, ShenyangLiaoning Province, 110004, China.
- Department of Mammary Gland, Dalian Women and Children's Medical Center (Group), DalianLiaoning Province, 116000, China.
- Department of General Surgery, Shengjing Hospital of China Medical University, ShenyangLiaoning Province, 110004, China. clu@cmu.edu.cn.
- Department of General Surgery, Shengjing Hospital of China Medical University, ShenyangLiaoning Province, 110004, China. yu.tian@cmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Shengjing Hospital
Zitieren
APA
Ma, C., Li, Y., Li, M., Lv, C., & Tian, Y. (2025). Targeting immune checkpoints on myeloid cells: current status and future directions. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03856-6
Vancouver
Ma C, Li Y, Li M, Lv C, Tian Y. Targeting immune checkpoints on myeloid cells: current status and future directions. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-024-03856-6
BibTeX
@article{Ma2025,
author = {Ma, Chuhan and Li, Yang and Li, Min and Lv, Chao and Tian, Yu},
title = {Targeting immune checkpoints on myeloid cells: current status and future directions},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
doi = {10.1007/s00262-024-03856-6}
}
EUVIMED